Using GSDMD-deficient mice, we found that growth of implanted breast cancer, known to be dependent on IL-1β, as well as of hepatoma tumors was independent of the expression of GSDMD in the tumor microenvironment. The gene discussed is IL1B; the disease is breast cancer.